QIAreach QuantiFERON-TB for the diagnosis of Mycobacterium tuberculosis infection

Eur Respir J. 2022 Mar 24;59(3):2102563. doi: 10.1183/13993003.02563-2021. Print 2022 Mar.

Abstract

QIAreach QFT demonstrated a good performance in diagnosing TB infection. This tool may offer technical and operational benefits over more complex IGRA ELISA-based assays, granting timely TB diagnosis in decentralised settings with limited infrastructure. https://bit.ly/3n6Dxll

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Interferon-gamma Release Tests
  • Latent Tuberculosis* / diagnosis
  • Mycobacterium tuberculosis*
  • Tuberculin Test
  • Tuberculosis* / diagnosis
  • Tuberculosis* / microbiology